Encouraging data with APOC3 siRNA in mixed hyperlipidemia
Christie Ballantyne, MD
Rationale for dietary fat recommendations in ASCVD prevention
Jacob J. Christensen, PhD
Bempedoic acid safe and effective in non-diabetic patients with metabolic syndrome
Pam R. Taub, MD, FACC, FASPC
ANGPTL3 RNAi therapeutic lowers atherogenic lipids and lipoproteins in patients with mixed hyperlipidemia
Robert S. Rosenson, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.